Skip to content
An Initiative of AVAC
Search
Back to Data by Country

Country Overview:
Australia

Global PrEP Tracker
Last Updated: 18 January 2023

Drug Registration Status

Approved
Not
Approved
Under
Review
Data not
available
Gilead's Truvada (TDF/xTC*) Registration
Approved
Generic versions of TDF/xTC* for prevention
Approved
Viiv's Apretude (CAB for PrEP) Registration
Approved
IPM's Dapivirine Vaginal Ring Registration
Not Approved
Oral F/TAF (Descovy) Registration
Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

7 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

2 Planned/Ongoing Projects

Policy Frameworks

Australia National PrEP Guidelines, 2021

Eighth National HIV Strategy, 2018-2022

Est. Cumulative
Initiations:

Total PrEP: 51,898

Oral PrEP: 51,898

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

PEPFAR Targets in
COP 2022:

Total PrEP: N/A

Oral PrEP: N/A

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Where To Access PrEP in Australia:

PAN PrEPaccessNOW

PrEPMap

HIV Care Now

Featured Resources

External Link

The Effect of Pre-exposure Prophylaxis (PrEP) on Negotiating Casual Sex between Gay Men: Disclosure, assumptions, and communication

This article from Sexual Health explores the disclosure of PrEP use, HIV status and communication with sex partners by HIV-negative gay men in Sydney, Australia.
External Link

Characterizing the Impact of the COVID-19 Pandemic on HIV PrEP care: A review and synthesis of the literature

This review from the journal AIDS and Behavior provides an examination of the influences of the COVID-19 pandemic on engagement in the PrEP care continuum, and looks at the barriers and facilitators to PrEP uptake during this time.
View All Resources